Say what you will about size, it's the numbers that really matter. Consider:
Women produce one egg a month, which birth control pills have been notably efficient in keeping corralled.
Men, however, come armed with hundreds of millions of sperm, so a successful male contraceptive has to deal with every one of the little buggers. Every one of them!
Little wonder, then, that promises of a male pill have rung as hollow as a morning-after's "I'll call you."
The sexual landscape may be changing, though, thanks to a University of Minnesota chemist who has developed a new approach to bringing men into the world of birth control, short of condoms or vasectomies.
Gunda Georg is a professor in the College of Pharmacy's Department of Medicinal Chemistry. She's also the one behind the joke that every room of the six-story building is used for research, "even the bathrooms." (More on that later.) The National Institutes of Health recently awarded Georg a $4.7 million grant for her contraceptive work.
In a nutshell, here's what's new: Most efforts to develop a male contraceptive use testosterone, but there are side effects: moodiness, which causes researchers to worry, or testicular shrinkage, which causes marketers to despair.
Also, men make sperm until the day they die, so any method may be used far longer than women's birth control. (Quick round of applause for menopause.) Finally, any method's effect has to be reversible.